Response to Letter to the Editor from Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism"

被引:0
|
作者
Monticone, Silvia [1 ,2 ]
Veglio, Franco [1 ,2 ]
Mulatero, Paolo [1 ,2 ]
机构
[1] Univ Torino, Div Internal Med 4, Dept Med Sci, I-10126 Turin, Italy
[2] Univ Torino, Dept Med Sci, Hypertens Unit, I-10126 Turin, Italy
来源
关键词
HYPERTENSION; SOCIETY;
D O I
10.1210/clinem/dgab719
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E896 / E897
页数:2
相关论文
共 50 条
  • [1] Letter to the Editor From Paolo Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism"
    Rossi, Gian Paolo
    Rossitto, Giacomo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (02): : E892 - E893
  • [2] Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism
    Pecori, Alessio
    Buffolo, Fabrizio
    Burrello, Jacopo
    Mengozzi, Giulio
    Rumbolo, Francesca
    Avataneo, Valeria
    D'Avolio, Antonio
    Rabbia, Franco
    Bertello, Chiara
    Veglio, Franco
    Mulatero, Paolo
    Monticone, Silvia
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (09): : E3655 - E3664
  • [3] EFFECTS OF MINERALOCORTICOID RECEPTOR ANTAGONISTS ON ALDOSTERONE TO RENIN RATIO IN PATIENTS WITH PRIMARY ALDOSTERONISM
    Pecori, Alessio
    Buffolo, Fabrizio
    Burrello, Jacopo
    Mengozzi, Giulio
    Rumbolo, Francesca
    Avataneo, Valeria
    D'Avolio, Antonio
    Rabbia, Franco
    Bertello, Chiara
    Veglio, Franco
    Mulatero, Paolo
    Monticone, Silvia
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E200 - E201
  • [4] Menopause not aldosterone-to-renin ratio predicts blood pressure response to a mineralocorticoid receptor antagonist in primary care hypertensive patients
    Olivieri, Oliviero
    Pizzolo, Francesca
    Ciacciarelli, Alberto
    Corrocher, Roberto
    Signorelli, Denise
    Falcone, Salvatore
    Blengio, Gian S.
    AMERICAN JOURNAL OF HYPERTENSION, 2008, 21 (09) : 976 - 982
  • [5] THE EFFECT OF RAMIPRIL ON THE ALDOSTERONE/RENIN RATIO AND THE ALDOSTERONE/ANGIOTENSIN II RATIO IN PATIENTS WITH PRIMARY ALDOSTERONISM
    Guo, Zeng
    Poglitsch, Marko
    Cowley, Diane
    Mcwhinney, Brett
    Ungerer, Jacobus
    Wolley, Martin
    Stowasser, Michael
    JOURNAL OF HYPERTENSION, 2021, 39 : E92 - E92
  • [6] THE EFFECT OF RAMIPRIL ON THE ALDOSTERONE/RENIN RATIO AND ALDOSTERONE/ANGIOTENSIN II RATIO IN PATIENTS WITH PRIMARY ALDOSTERONISM: A PILOT STUDY
    Guo, Z.
    Cowley, D.
    Poglitsch, M.
    McWhinney, B.
    Ungerer, J.
    Wolley, M.
    Stowasser, M.
    JOURNAL OF HYPERTENSION, 2019, 37 : E30 - E31
  • [7] Variability of aldosterone, renin and the aldosterone-to-renin ratio in hypertensive patients without primary aldosteronism
    Veldhuizen, Gregory P.
    Alnazer, Rawan M.
    Kroon, Abraham A.
    de Leeuw, Peter W.
    JOURNAL OF HYPERTENSION, 2022, 40 (11) : 2256 - 2262
  • [8] Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design
    Giacomo Rossitto
    Maurizio Cesari
    Giulio Ceolotto
    Giuseppe Maiolino
    Teresa Maria Seccia
    Gian Paolo Rossi
    Journal of Human Hypertension, 2019, 33 : 167 - 171
  • [9] Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study
    Rossi, Gian Paolo
    Ceolotto, Giulio
    Rossitto, Giacomo
    Maiolino, Giuseppe
    Cesari, Maurizio
    Seccia, Teresa Maria
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (06): : 2060 - 2067
  • [10] Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism
    Guo, Zeng
    Poglitsch, Marko
    Cowley, Diane
    Domenig, Oliver
    McWhinney, Brett C.
    Ungerer, Jacobus P. J.
    Wolley, Martin
    Stowasser, Michael
    HYPERTENSION, 2020, 76 (02) : 488 - 496